Effect of donor age on patellar tendon allograft ACL reconstruction

A Prospective, Double-Blind Evaluation of Anterior Cruciate Ligament Reconstruction With Tibialis Tendon Allograft: Donor Age Does Not Alter Outcomes

Purpose

To evaluate the effect of graft donor age on outcomes of anterior cruciate ligament (ACL) reconstruction with nonirradiated, fresh-frozen tibialis tendon allografts.

Methods

This prospective, randomized, double-blind, single surgeon, 2-year follow-up study enrolled 40 patients (28 female, 12 male who underwent ACL reconstruction with tibialis tendon allografts. Results were compared with historical outcomes for allografts from donors aged 18 to 70 years. Analysis was determined by Group A (<50 years) and Group B (>50 years). Objective and subjective International Knee Documentation Committee (IKDC) forms, KT-1000 testing, and Lysholm scores were used for the evaluation.

Results

Follow-up on average of 24 months was completed in 37 patients (92.5%; Group A = 17, Group B = 20). Average patient age at surgery for Group A was 42.1 years (range 27-54) and Group B was 41.7 years (range 24-56). None of the patients required additional surgery during the initial 2-year follow-up. At 2-year follow-up, there were no significant differences in subjective outcomes. IKDC objective ratings for Group A were A-15 and B-2, and Group B were A-19 and B-1 (P = .45). Average IKDC subjective scores for Group A were 86.1 (± 16.2) and Group B were 84.1 (± 15.6) (P = .70). KT-1000 side to side differences for Group A were 0-4, 1-10, and 2-2, and Group B were 0-2, 1-10, 2-6 (P = .28). Average Lysholm scores for Group A were 91.4 (± 16.7) and Group B were 88.1 (± 12.3) (P = .49).

Conclusions

Donor age was not associated with clinical outcomes after ACL reconstruction using nonirradiated, fresh-frozen tibialis tendon allografts.

Level of Evidence

II, prospective prognostic trial.

Management of Intraoperative Graft-related Challenges in Anterior Cruciate Ligament Reconstruction

Anterior cruciate ligament reconstruction (ACLR) is one of the most frequently performed procedures in orthopaedic sports medicine. Intraoperative challenges related to graft procurement, graft preparation, and graft placement are common. Frequently encountered difficulties include insufficient graft diameter and graft-tunnel length mismatches, whereas less frequent challenges may be encountered during graft harvest and handling. This article discusses these possible complications and the strategies for their prevention and management. For successful ACLR, clinicians must be prepared to address each of these potential sources of difficulty.

Influence of Age on Signal Intensity of Magnetic Resonance Imaging and Clinical Outcomes in Double-Bundle Anterior Cruciate Ligament Reconstruction: Comparisons Among Different Age Groups

BACKGROUND

Thus far, the clinical results of anterior cruciate ligament (ACL) reconstruction have been observed to be comparable between young and older patients. In contrast, age-related changes in the structural and mechanical properties of tendons used for autografts have been described. However, age-related changes associated with graft maturation remain poorly understood.

HYPOTHESES

The hypotheses of this study were that (1) clinical outcomes after ACL reconstruction would be comparable between younger and relatively older patients and (2) younger patients would show lower signal intensity changes on magnetic resonance imaging scans indicative of graft maturation that would be better than that in relatively older patients.

STUDY DESIGN

Cohort study; Level of evidence, 3.

METHODS

We retrospectively evaluated 236 patients who underwent double-bundle ACL reconstruction via the outside-in technique using hamstring autograft between January 2012 and December 2015. The patients were categorized by age into 3 groups: <20 years old, 20 to 39 years old, and ≥40 years old. Clinical outcomes were evaluated using the subjective International Knee Documentation Committee (IKDC) score, Tegner activity scale, Lysholm score, and objective assessment of joint laxity 24 months after surgery. In addition, graft maturation was evaluated using magnetic resonance imaging-derived measures of the signal intensity ratio (SIR) at 3, 6, 12, and 24 months postoperatively. Clinical outcomes and graft maturation were compared among the 3 groups.

RESULTS

The SIR of both bundles increased from 3 months to 12 months and decreased by 24 months, showing the same tendency in all groups. No significant difference was found in the SIR among the 3 groups at any time point (P > .05). The IKDC score was significantly lower in the ≥40-year group than in the <20-year group (P < .01). In contrast, no significant differences were noted in other clinical outcomes.

CONCLUSION

Patients aged ≥40 years exhibited lower IKDC scores compared with younger patients, although the results of graft maturation were comparable.

Aging Decreases the Ultimate Tensile Strength of Bone-Patellar Tendon-Bone Allografts

PURPOSE

The purpose of this study was to determine whether aging imparts a clinically significant effect on the (1) mechanism of graft failure and (2) structural, material, and viscoelastic properties of patellar tendon allografts by evaluating these properties in younger donors (≤30 years of age) and older donors (>50 years of age).

METHODS

A total of 34 younger (≤30 years of age) and 34 older (>50 years of age) nonirradiated, whole bone-tendon-bone allografts were prepared for testing by isolating the central third of the patellar tendon using a double-bladed 10-mm width scalpel under a 10-N load to ensure uniformity of harvest. Bone blocks were potted in polymethylmethacrylate within custom molds. Tendon length and cross-sectional area were measured using an area micrometer. A mechanical loading system was used to precondition the grafts for 100 cycles with a load between 50 N and 250 N (1 Hz). A creep load (500 N) was then applied at a rate of 100 mm/min (10 minutes). Grafts were allowed to recover at 1 N (10 minutes), followed by pull-to-failure at a rate of 100% strain per second. Mechanisms of failure (midsubstance vs avulsion) were noted and the structural, material, and viscoelastic properties calculated and compared between groups.

RESULTS

There were 33 (97%) midsubstance tears in the younger group and 28 (82%) in the older group (P = .034). Younger grafts showed greater ultimate load to failure (1,782 N [1,533, 2,032] vs 1,319 N [1,103, 1,533]) (P = .006) and ultimate tensile stress (37.4 MPa [32.4, 42.4] vs 27.5 MPa [22.9, 32.0]) (P = .006). There were no significant differences in displacement (P = .595), stiffness (P = .950), strain (P = .783), elastic modulus (P = .114), creep displacement (P = .881), and creep strain (P = .614).

CONCLUSIONS

This in vitro study suggests that aging weakens the bone-tendon junction and decreases the ultimate tensile strength of patellar tendon allografts. However, aging did not affect the displacement, strain, stiffness, elastic modulus, creep displacement, or creep strain of patellar tendon allografts.

CLINICAL RELEVANCE

Surgeons should be aware that patellar tendon allografts from donors >50 years of age have a lower ultimate tensile stress than donors ≤30 years of age.

Use of Allografts in Orthopaedic Surgery: Safety, Procurement, Storage, and Outcomes

The use of allografts has become a vital option for orthopaedic surgeons in the treatment of a variety of musculoskeletal lesions, ranging from osteochondral defects in the glenohumeral joint to meniscal deficiency in the young athlete. Nevertheless, barriers to treating a patient with an allograft-based procedure may arise from concerns over disease transmission, the navigation of tissue banks that supply allografts, the process of obtaining insurance approval, or optimal storage methods. This review serves to support orthopaedic surgeons in the incorporation of allografts into their practice by quelling these potential concerns. Fresh osteochondral allografts, fresh-frozen meniscal allografts, soft tissue allografts, and off-the-shelf cartilage products are the focus of this review amid broad overviews of allograft safety and tissue bank practices in the United States.

Biomechanical and geometric characterization of peroneus longus allografts with respect to age

BACKGROUND

Anterior cruciate ligament injuries are among the most common injuries in high impact sports, and reconstruction is the standard surgical procedure for these ruptures. Reconstructions are often performed using allografts rather than autografts on a case-by-case basis. Controversy exists as to whether or not age of donor tissue plays a factor in the mechanical properties of allografts.

METHODS

38 peroneus longus (PL) tendons were prepared using the two-strand graft technique and then subjected to a cyclic loading test regimen of 1000 cycles to determine material properties. Specimens were grouped based on age to ascertain whether donor age affects the material properties of PL tendons.

FINDINGS

Secant modulus of the first cycle was determined to be 150.43 (SD 40.24) MPa. The average magnitude of the dynamic modulus was determined to be 82.81 (SD 24.65) MPa. Specimens were grouped into three distinct groups for analysis (x < 40 yo, 40 yo ≤ x < 60 yo, 60 yo < x).

INTERPRETATION

The need for using intrinsic material properties is highlighted. There is no significant difference in any intrinsic material property with respect to age or the fatigue of the tendon as the cycle count increases. Conversely, the measured stiffness of a tendon decreased as function of age with a large effect size. Based on analysis of graft geometries, it was determined that PL tendons become significantly more slender with increased age which result in the observed decrease in stiffness.

Does Donor Age of Nonirradiated Achilles Tendon Allograft Influence Mid-Term Results of Revision ACL Reconstruction?

Purpose  The purpose of the present study was to investigate if the donor age of nonirradiated Achilles tendon allograft could influence the clinical results of revision anterior cruciate ligament (ACL) reconstruction.

Methods  All patients that underwent ACL revision between 2004 and 2008 with at least 4 years of follow-up were included. For all the patients that met the inclusion criteria, the age of the graft donor was obtained from the tissue bank. Lysholm score was administered to patients that met inclusion criteria. In addition, patients were divided in two groups based on the donor age (<45 years vs. ≥45 years), and the baseline characteristics and outcomes were compared.

Results  Fifty-two patients were evaluated at a mean 4.8 ± 0.8 years follow-up with Lysholm score. The Lysholm significantly improved from 62.3 ± 6.6 at preoperative status to 84.4 ± 12.3 at final follow-up. The mean donor age was 48.7 ± 8.4 years; a significant difference in Lysholm score was noted between patients that received an allograft with a donor age <45 years (14 patients; 27%) and those receiving an allograft with a donor age ≥45 years (38; 73%) (89.5 ± 3.2 vs. 80.1 ± 11.1, respectively; p  = 0.0469). The multiple regression model showed the donor age, the final follow-up, and the preoperative Lysholm score as significant predictors of postoperative Lysholm score ( p  < 0.0002).

Conclusion  Donor age of nonirradiated Achilles tendon allograft influenced the mid-term results of revision ACL reconstruction, thus advising the use of grafts from young donors.

Level of Evidence  Level III, retrospective comparative study.

Morphological and molecular characterization of human hamstrings shows that tendon features are not influenced by donor age

PURPOSE

Age-related modifications of tendons, such as reduced tenocyte proliferation and modified extracellular matrix (ECM) turnover, have been previously described, but results are often incomplete and discordant. The aim of this study was to investigate, using morphological and molecular methods, the effect of ageing on human tendons and tenocytes, especially focusing on the collagen turnover pathways, in order to understand how the ageing process could influence tendon biology and structure.

METHODS

Morphological analysis was performed on fragments from human semitendinosus and gracilis tendons harvested from 10 adult (mean age 41.8 ± 13.3 years) and 6 aged healthy patients (mean age 72.7 ± 7.0 years) by haematoxylin and eosin, Sirius red and Alcian blue staining. The expression of genes and proteins involved in collagen turnover and focal adhesions was assessed by real-time PCR, slot blot and zymography in cultured tenocytes. Cytoskeleton arrangement was studied by immunofluorescence and cell migration by wound healing assay.

RESULTS

The structure and composition of ECM in ageing tendons are preserved as well as the expression of genes and proteins involved in collagen turnover pathways. Although morphological analysis revealed that ageing tenocytes tended to an impaired migration potential and that actin filaments are occasionally shorter and randomly distributed, the expression of proteins involved in focal adhesion formation is preserved.

CONCLUSION

Results of this study suggest that the structure of ageing tendons is preserved and that ageing tenocytes maintain their ability for ECM remodelling, supporting the hypothesis that ageing tendons maintain their biomechanical properties. The biological reliability of aged tendons has a clinical relevance, supporting the use of tendon autografts also in the elderly patients. Since the common and successful orthopaedic procedure of anterior cruciate ligament reconstruction using either autografts or allografts is becoming more common in older age groups, these findings suggest that the donor age would not significantly influence the clinical outcome.

Biomechanical Strength and Elongation of the T-Block Modification for Bone-Patella Tendon-Bone Allografts

PURPOSE

To assess the biomechanical performance of 2 different T-block modifications of bone-patella tendon-bone (BPTB) allografts.

METHODS

The matched knee pairs from 10 human cadavers (mean age 49 years) were fashioned into 30 BPTB allografts and divided into 3 groups (10 each): group 1, standard patella tendon-tibial attachment; group 2, T-block tibial attachment with 10 mm of unattached bone proximal to the patella tendon insertion with 15 mm of tendon attached; group 3, T-block tibial attachment with 15 mm of unattached bone proximal to the patella tendon insertion and 10 mm of tendon attached. A biocomposite interference screw secured each graft into a 10-mm tunnel in 15 pcf polyurethane foam. A 10-N preload was applied followed by 500 cycles of 10- to 150-N loading at 0.5 Hz. Grafts completing cyclic loading were destructively tested at 200 mm/min. Failure load, stiffness, elongation, and failure mode were recorded.

RESULTS

Failure loads and elongation for groups 1, 2, and 3 (790, 729, and 700 N; 0.15, 0.16, and 0.19 mm, respectively) were not statistically different (P > .1). Graft stiffness for groups 1 and 2 (214 and 186 N/mm) were not statistically different, but group 3 (170 N/mm) was different from group 1. All group 1 and 2 tests failed by graft pullout as did 8 of 10 from group 3. The other 2 failed by tendon tearing from bone.

CONCLUSIONS

A T-block BPTB allograft harvested with 10 or 15 mm of unattached bone proximal to the tibial patella tendon insertion has no ultimate failure strength difference after cyclic loading compared with the standard BPTB allograft. The 15-mm T-block showed lower stiffness and more elongation at failure than the standard BPTB allograft whereas the 10-mm T-block exhibited comparable stiffness and elongation measurements to the standard BPTB allograft control specimens.

CLINICAL RELEVANCE

The T-block BPTB allograft construct should increase the availability of BPTB allografts for anterior cruciate ligament reconstruction and facilitate the use of grafts possessing longer tendon segments that are currently being discarded.

Revision Risk After Allograft Anterior Cruciate Ligament Reconstruction: Association With Graft Processing Techniques, Patient Characteristics, and Graft Type

BACKGROUND

Allograft tissue is a common graft choice for anterior cruciate ligament reconstruction (ACLR). Allograft sterilization methods vary widely across numerous commercial tissue vendors. Multiple studies, despite being limited in sample size, have suggested a higher rate of clinical failure associated with the use of allograft tissue in ACLR when compared with autograft.

PURPOSE

To examine the association of graft processing techniques, patient characteristics, and graft type with risk of revision surgery after allograft ACLR.

STUDY DESIGN

Cohort study; Level of evidence, 3.

METHODS

A retrospective cohort study was conducted that used an integrated United States health care system's ACLR registry to identify primary unilateral cases in which allografts were used. Aseptic revision was the endpoint of the study. Allograft type, processing methods (irradiation dose, AlloWash, AlloTrue, BioCleanse), and graft donor age were assessed as potential risk factors for revision, with adjustment for patient age, sex, and body mass index (BMI) by use of survival analysis. Hazard ratios (HR) and 95% confidence intervals (CIs) were calculated.

RESULTS

A total of 5968 primary ACLR cases with allograft were included in the study, of which 3688 (61.8%) were male patients. The median age of the cohort at the time of surgery was 34.1 years (interquartile range, 24.1-42.9 years). The mean time to follow-up (±SD) was 2.1 ± 1.5 years. There were 3751 (62.9%) allograft ACLRs using soft tissue, 1188 (19.9%) with Achilles tendon, and 1029 (17.2%) with bone-patellar tendon-bone (BPTB). Graft processing groups included BioCleanse (n = 367), AlloTrue or AlloWash (n = 2278), irradiation greater than 1.8 Mrad (n = 1146), irradiation up to 1.8 Mrad (n = 3637), and no irradiation (n = 1185). There were 156 (2.6%) aseptic revisions. After adjustment for patient age, sex, and BMI, the use of BioCleanse (HR = 2.45; 95% CI, 1.36-4.40) and irradiation greater than 1.8 Mrad (HR = 1.64; 95% CI, 1.08-2.49) were associated with a higher risk of revision when compared with all other methods of processing. BPTB allografts were at higher risk of revision (HR = 1.79; 95% CI, 1.20-2.66) when compared with soft tissue allografts. Conversely, with every 5-year increase in age, the risk of revision was 0.67 (95% CI, 0.61-0.73) times lower. Male patients were found to be at higher risk of revision when compared with females (HR = 1.47; 95% CI, 1.04-2.07). The use of AlloWash or AlloTrue processing, patient BMI, and graft donor age did not affect revision rate significantly.

CONCLUSION

In the largest known study of its kind examining outcome after primary allograft ACLR, graft irradiation greater than 1.8 Mrad, BioCleanse graft processing, younger patient age, male patients, and BPTB allograft were all associated with a higher risk of clinical failure and subsequent revision surgery.